Q4 2024 Earnings Call Transcript January 22, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.04, ...

Johnson & Johnson ( JNJ) beat on fourth quarter and full-year 2024 results, but its stock traded down on Wednesday morning to ...

And regular polling carried out by YouGov suggests adults are increasingly likely to say that vaccines have harmful side ...

Mr. Kennedy, on the other hand, is a vaccine cynic, failing to accept studies that refute his beliefs. He claims that the ...

Johnson & Johnson’s latest earnings bested Wall Street estimates, as the company braces for one of its top-selling medicines ...

Asked on WISN's "Upfront" on Nov. 17 about his praise for Kennedy and false claims about vaccines causing autism, Johnson ...

With the coming of a new year—and a new administration—there have been unsettling indications that some long-standing public health policies and evidence-based healthcare recommendations may be ...

This report covers recent health news, including Robert F. Kennedy Jr.'s legal fees from Merck litigations, rejections of a ...

Analyst Tim Anderson of Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research Report), reducing the ...

NEW YORK — Johnson & Johnson will spend more than $14 billion to delve further into the treatment of central nervous system disorders by purchasing Intra-Cellular Therapies. The health care giant said ...